Atlas Trials

Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1

Clinical trial NCT04886518 · COMPLETED

Trial details

NCT number
NCT04886518
Sponsor
Harmony Biosciences Management, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myotonic Dystrophy 1Excessive Daytime Sleepiness
Start date
2021-06-28
Primary completion
2023-10-06
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.